Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24MLH1andMSH2Gene Variants-Reference-Cited by-同舟云学术

Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24MLH1andMSH2Gene Variants

Published:2016-10-17 Issue:1 Volume:38 Page:64-77
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Tricarico Rossella¹²,Kasela Mariann³,Mareni Cristina⁴,Thompson Bryony A.⁵⁶,Drouet Aurélie⁷,Staderini Lucia¹⁸,Gorelli Greta¹,Crucianelli Francesca¹,Ingrosso Valentina¹,Kantelinen Jukka³,Papi Laura¹,De Angioletti Maria⁹¹⁰,Berardi Margherita⁹,Gaildrat Pascaline⁷,Soukarieh Omar⁷,Turchetti Daniela¹¹,Martins Alexandra⁷,Spurdle Amanda B.¹²,Nyström Minna³,Genuardi Maurizio¹¹³,

Affiliation:

1. Department of Biomedical, Experimental and Clinical Sciences, Medical Genetics Unit; University of Florence; Florence Italy

2. Cancer Epigenetics and Cancer Biology Programs; Fox Chase Cancer Center; Philadelphia Pennsylvania

3. Department of Biosciences, Division of Genetics; University of Helsinki; Helsinki Finland

4. Tuscan Tumor Institute; Florence Italy

5. Department of Oncological Sciences, Huntsman Cancer Institute; University of Utah; Salt Lake City Utah

6. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health; University of Melbourne; Victoria Australia

7. Inserm-U1079-IRIB, Normandy Centre for Genomic and Personalized Medicine; University of Rouen; Rouen France

8. Microbiology and Virology Department; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

9. Cancer Genetics and Gene Transfer - Core Research Laboratory; Istituto Toscano Tumori; Florence Italy

10. ICCOM-CNR; Sesto Fiorentino; Italy

11. Medical Genetics, Department of Medical and Surgical Sciences (DIMEC); University of Bologna; Bologna Italy

12. Genetics and Computational Biology Department; QIMR Berghofer Medical Research Institute; Brisbane Australia

13. Institute of Genomic Medicine, A. Gemelli School of Medicine, Medical Genetics Unit; Catholic University of the Sacred Heart; Rome Italy

Funder

Istituto Toscano Tumori

National Health and Medical Research Council

National Institutes of Health

European Research Council

Institut National Du Cancer

Fondation ARC pour la Recherche sur le Cancer

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference60 articles.

1. The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis;Alemayehu;Neoplasma,2007

2. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics;Arnold;Hum Mutat,2009

3. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing;Auclair;Hum Mutat,2006

4. Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2;Betz;J Cancer Res Clin Oncol,2010

5. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer;Boland;Cancer Res,1998

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study;Annals of Medicine;2024-09-11

2. Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review;Cancers;2023-12-21

3. Susceptibility Genes Associated with Multiple Primary Cancers;Cancers;2023-12-10

4. Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome;Cancers;2023-12-08

5. The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome;Frontiers in Oncology;2023-07-19